Details for New Drug Application (NDA): 020768
✉ Email this page to a colleague
The generic ingredient in ZOMIG is zolmitriptan. There are twenty drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the zolmitriptan profile page.
Summary for 020768
Tradename: | ZOMIG |
Applicant: | Ipr |
Ingredient: | zolmitriptan |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 2.5MG | ||||
Approval Date: | Nov 25, 1997 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
Approval Date: | Nov 25, 1997 | TE: | RLD: | Yes |
Expired US Patents for NDA 020768
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Ipr | ZOMIG | zolmitriptan | TABLET;ORAL | 020768-002 | Nov 25, 1997 | ⤷ Try a Trial | ⤷ Try a Trial |
Ipr | ZOMIG | zolmitriptan | TABLET;ORAL | 020768-002 | Nov 25, 1997 | ⤷ Try a Trial | ⤷ Try a Trial |
Ipr | ZOMIG | zolmitriptan | TABLET;ORAL | 020768-001 | Nov 25, 1997 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription